Financials
Financial year 2025
DR. VROLIX from Genk, company number BE0456470122, closed financial year 2025 with a result of € 561,157 after tax. For that financial year DR. VROLIX recorded a gross margin of € 897,337 and equity of € 2.9 million. Compared with financial year 2024, the result moved from € 319,145 to € 561,157. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 2.9 million
▲ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 561,157
▲ 76% vs 2024
Profit after tax over the fiscal year.
€ 288,783
▼ 53% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.9 million.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 35,655
▼ 6% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,352
▼ 80% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 33,154
▲ 3% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,080,319 | € 372,569 | € 357,696 | € 897,337 | ▲ 151% |
| Profit after taxes | € 867,325 | € 196,672 | € 319,145 | € 561,157 | ▲ 76% |
| Equity | € 2,333,481 | € 2,530,153 | € 2,318,835 | € 2,879,992 | ▲ 24% |
| Total debts | € 646,451 | € 242,379 | € 783,661 | € 37,747 | ▼ 95% |
| Cash | € 296,667 | € 144,075 | € 610,746 | € 288,783 | ▼ 53% |
| Land & buildings | € 158,175 | € 108,678 | € 105,134 | € 60,000 | ▼ 43% |
| Retained profit | € 2,314,881 | € 2,511,553 | € 2,300,235 | € 2,861,392 | ▲ 24% |
| Dividend | € 0 | € 0 | € 530,464 | € 0 | ▼ 100% |
| Bank debt | € 366,034 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 2,979,932 | € 2,772,532 | € 3,102,495 | € 2,917,739 | ▼ 6% |
By gross margin, DR. VROLIX ranks 3rd of 92 companies with main activity “Activiteiten van medisch specialisten” in Genk that publish figures (fiscal year 2025).
Key figures of DR. VROLIX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about DR. VROLIX the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DR. VROLIX?
What happened at DR. VROLIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 561,157 (▲ 76% vs 2024). filed late Source: NBB ↗
- MATHIAS CHRISTIAAN VROLIX became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 867,325 profit in 2022 to € 561,157 profit in 2025.
Paid € 992,094 in corporate taxes since 2022.
Best year ever: 2022, with € 867,325 profit.
Paid out € 530,464 in dividends to the owners in total.
Management
Behind DR. VROLIX is MATHIAS CHRISTIAAN VROLIX.
Directors
According to the 2025 annual accounts
MATHIAS CHRISTIAAN VROLIX
Director
since 1995
Establishments
Establishment units
Physical locations of this company
Richter 20
3600 Genk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Genk
Same main activity (Activiteiten van medisch specialisten), 107 active companies in Genk, largest first.
Medische Beeldvorming Ziekenhuis Oost-Limburg
€ 21 million revenue · 2025
BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENT
€ 2.4 million gross margin · 2025
€ 1.2 million gross margin · 2025
€ 859,250 gross margin · 2025
€ 818,343 gross margin · 2025
€ 781,629 gross margin · 2025
Details
- Company number
- 0456.470.122
- VAT number
- BE 0456.470.122
- Registered office
- Richter 20, 3600 Genk
- Names & denominations
- DR. VROLIX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 November 1995
- Peppol
- Active · Active since 18 Mar 2025
- Activities · NACE
Activiteiten van medisch specialisten
Organisatie van congressen en beurzen